Episteme Prognostics

About:

Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.

Website: https://www.epistemedx.com/

Description:

Episteme Prognostics is a precision medicine company that develops therapeutic biomarkers for pancreatic cancer. It predicts chemotherapy response and assesses the benefit of epigenetic therapy to pancreatic cancer patients.

Total Funding Amount:

$4.11M

Headquarters Location:

New York, New York, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)epistemedx.com

Founders:

Steven Leach, Surajit Dhara

Number of Employees:

Last Funding Date:

2023-04-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai